Skip to menu Skip to content Skip to footer

2006

Journal Article

Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope

Smith, Corey, Cooper, Leanne, Burgess, Melinda, Rist, Michael, Webb, Natasha, Lambley, Eleanore, Tellam, Judy, Marlton, Paula, Seymour, John F., Gandhi, Maher and Khanna, Rajiv (2006). Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope. Journal of Immunology, 177 (7), 4897-4906. doi: 10.4049/jimmunol.177.7.4897

Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope

2006

Journal Article

Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty?

Gandhi, Maher and Khanna, Rajiv (2006). Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty?. Leukemia and Lymphoma, 47 (5), 779-780. doi: 10.1080/10428190600580973

Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty?

2006

Journal Article

Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836

Gandhi, M and Khanna, R (2006). Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836. Leukemia & Lymphoma, 47 (5), 779-780. doi: 10.1080/10428190600580973

Epstein-Barr virus and advanced chronic lymphocytic leukemia: innocent until proven guilty? Commentary on: Tsimberidou et al. Epstein-Barr virus in patients with chronic lymphocytic leukemia: A pilot study. Leuk Lymphoma 2006; 47 : 827-836

2006

Journal Article

Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma

Wilson, W. M., Dua, U., Grigg, A. P. and Gandhi, M. K. (2006). Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. Leukemia & Lymphoma, 47 (5), 871-876. doi: 10.1080/10428190600649562

Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma

2006

Journal Article

Epstein-Barr virus-associated lymphomas

Gandhi, M. K. (2006). Epstein-Barr virus-associated lymphomas. Expert Review of Anti-Infective Therapy, 4 (1), 77-89. doi: 10.1586/14737140.4.1.77

Epstein-Barr virus-associated lymphomas

2006

Journal Article

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients

Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006). Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 (7), 2280-2289. doi: 10.1182/blood-2006-04-015164

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients

2006

Journal Article

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma

Gandhi, M. K., Lambley, E., Burrows, J., Dua, U., Elliott, S., Shaw, P. J., Prince, H. M., Wolf, M., Clarke, K., Underhill, C., Mills, T., Mollee, P., Gill, D., Marlton, P., Seymour, J. F. and Khanna, R. (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research, 12 (2), 460-464. doi: 10.1158/1078-0432.CCR-05-2008

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma

2005

Journal Article

Viruses and lymphoma

Gandhi, Maher K. and Khanna, Rajiv (2005). Viruses and lymphoma. Pathology, 37 (6), 420-433. doi: 10.1080/003130200500368303

Viruses and lymphoma

2005

Journal Article

Regulation of clinical research

Gandhi, Maher K. (2005). Regulation of clinical research. Clinical Medicine, 5 (3), 299-299. doi: 10.7861/clinmedicine.5-3-299

Regulation of clinical research

2005

Journal Article

Follicular lymphoma: Time for a re-think?

Gandhi, Maher K. and Marcus, Robert E. (2005). Follicular lymphoma: Time for a re-think?. Blood Reviews, 19 (3), 165-178. doi: 10.1016/j.blre.2004.09.001

Follicular lymphoma: Time for a re-think?

2005

Journal Article

Technology Insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies

Khanna, Rajiv, Moss, Denis and Gandhi, Maher (2005). Technology Insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies. Nature Clinical Practice Oncology, 2 (3), 138-149. doi: 10.1038/ncponc0107

Technology Insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies

2005

Conference Publication

LAG-3 expressing lymphocytes suppress EBV latent membrane protein-specific T cell function in Hodgkins lymphoma patients

Gandhi, M, Lambley, E, Marlton, P, Gill, D, Seymour, J, Wolf, M, Prince, M, Elliott, S and Khanna, R (2005). LAG-3 expressing lymphocytes suppress EBV latent membrane protein-specific T cell function in Hodgkins lymphoma patients. 9th International Conference on Malignant Lymphoma, Lugano Switzerland, Jun 09-11, 2005. OXFORD: OXFORD UNIV PRESS.

LAG-3 expressing lymphocytes suppress EBV latent membrane protein-specific T cell function in Hodgkins lymphoma patients

2004

Journal Article

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments

Gandhi, Maher K. and Khanna, Rajiv (2004). Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infectious Diseases, 4 (12), 725-738. doi: 10.1016/S1473-3099(04)01202-2

Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments

2004

Journal Article

Epstein-Barr virus-associated Hodgkin's lymphoma

Gandhi, Maher K., Tellam, Judy T. and Khanna, Rajiv (2004). Epstein-Barr virus-associated Hodgkin's lymphoma. British Journal of Haematology, 125 (3), 267-281. doi: 10.1111/j.1365-2141.2004.04902.x

Epstein-Barr virus-associated Hodgkin's lymphoma

2003

Journal Article

Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation

Gandhi, MK, Wills, MR, Sissons, JGP and Carmichael, AJ (2003). Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation. Blood Reviews, 17 (4), 259-264. doi: 10.1016/S0268-960X(03)00028-6

Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation

2003

Journal Article

Late diversification in the clonal composition of human cytomegalovirus-specific CD8(+) T cells following allogeneic hemopoietic stem cell transplantation

Gandhi, MK, Wills, MR, Okecha, G, Day, EK, Hicks, R, Marcus, RE, Sissons, JGP and Carmichael, AJ (2003). Late diversification in the clonal composition of human cytomegalovirus-specific CD8(+) T cells following allogeneic hemopoietic stem cell transplantation. Blood, 102 (9), 3427-3438. doi: 10.1182/blood-200-12-3689

Late diversification in the clonal composition of human cytomegalovirus-specific CD8(+) T cells following allogeneic hemopoietic stem cell transplantation

2003

Journal Article

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study

Gandhi, MK, Lekamwasam, S, Inman, I, Kaptoge, S, Sizer, L, Love, S, Bearcroft, PW, Milligan, TP, Price, CP, Marcus, RE and Compston, JE (2003). Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study. British Journal of Haematology, 121 (3), 462-468. doi: 10.1046/j.1365-2141.2003.04303.x

Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study

2002

Journal Article

Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell response

Wills, MR, Okecha, G, Weekes, MP, Gandhi, MK, Sissons, PJG and Carmichael, AJ (2002). Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell response. Journal of Immunology, 168 (11), 5455-5464. doi: 10.4049/jimmunol.168.11.5455

Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: Analysis of the human cytomegalovirus-specific CD8(+) T cell response

2001

Conference Publication

Identification of novel proteins associated with the Mpl cytoplasmic domain.

Gandhi, M and Drachman, JG (2001). Identification of novel proteins associated with the Mpl cytoplasmic domain.. WASHINGTON: AMER SOC HEMATOLOGY.

Identification of novel proteins associated with the Mpl cytoplasmic domain.

2001

Conference Publication

Significant and persistant loss of bone mineral density (BMD) in the femoral neck after haematopoietic stem cell transplantation: A prospective study.

Gandhi, MK, Lekamwasam, S, Inman, , Kaptoge, S, Sizer, L, Love, S, Craig, JIO, Marcus, RE and Compston, J (2001). Significant and persistant loss of bone mineral density (BMD) in the femoral neck after haematopoietic stem cell transplantation: A prospective study.. WASHINGTON: AMER SOC HEMATOLOGY.

Significant and persistant loss of bone mineral density (BMD) in the femoral neck after haematopoietic stem cell transplantation: A prospective study.